June 18, 2020 / 1:28 PM / 18 days ago

BRIEF-GSK Prices $280.3 Mln Notes Due 2023 Exchangeable Into Theravance Biopharma Shares

June 18 (Reuters) - GlaxoSmithKline PLC:

* GSK - GSK PRICES $280.3 MILLION SENIOR NOTES DUE 2023 EXCHANGEABLE INTO THERAVANCE BIOPHARMA ORDINARY SHARES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below